In 2002, a handful of entrepreneurs began supplying drugs from Canada into the United States, using the normative and the price difference between the neighboring countries. Using the Internet and inexpensive online Canadian pharmacies, firms such as Rx Depot allowed U.S. customers to order prescription drugs in the United States to get them at a significant discount to the prevailing prices in the U.S. and deliver drugs directly to their homes. It was a powerful business model that has made Rx Depot major player. In November 2003, however, the U.S. Court ruled that Rx Depot violated federal law. The company was forced to close, but its founder, Carl Moore, said that he was ready to fight. Is Rx Depot just breech U.S. intellectual property laws? Or his actions show that the laws were ready for a change? "Hide
by Adam Day, Debora L. Spar Source: Harvard Business School 14 pages. Publication Date: February 3, 2005. Prod. #: 705010-PDF-ENG
Related Case Solutions & Analyses:
Financial Statements and Ratio Analysis
Jeffrey Sonnenfeld (B): The Road to Redemption
Emerging Networked Business Models: Lessons from the Field
Note on Valuing Equity Cash Flows
Industrial Relations Issue In Irish Rail (Iarnród Éireann)
Google’s Case Questions
DonorsChoose.org: How Technology Facilitated a New Funding Model
Proximity Designs
Spss Assignment
Westmont Retirement
